Growth Metrics

GoodRx Holdings (GDRX) Accumulated Depreciation & Amortization (2019 - 2025)

GoodRx Holdings' Accumulated Depreciation & Amortization history spans 7 years, with the latest figure at $22.3 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 22.27% to $22.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $22.3 million, a 22.27% increase, with the full-year FY2025 number at $22.3 million, up 22.27% from a year prior.
  • Accumulated Depreciation & Amortization hit $22.3 million in Q4 2025 for GoodRx Holdings, up from $18.2 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for GDRX hit a ceiling of $22.3 million in Q4 2025 and a floor of $5.8 million in Q4 2021.
  • Historically, Accumulated Depreciation & Amortization has averaged $14.0 million across 5 years, with a median of $13.8 million in 2023.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 173.66% in 2021 and later grew 22.27% in 2025.
  • Tracing GDRX's Accumulated Depreciation & Amortization over 5 years: stood at $5.8 million in 2021, then skyrocketed by 67.59% to $9.8 million in 2022, then surged by 41.12% to $13.8 million in 2023, then surged by 32.24% to $18.2 million in 2024, then rose by 22.27% to $22.3 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for GDRX at $22.3 million in Q4 2025, $18.2 million in Q4 2024, and $13.8 million in Q4 2023.